Invus Global Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT)

Filing Manager: Invus Global Management, LLC
Reporting Manager: Raymond Debbane
Security: vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share
Symbol: VTVT
Shares outstanding: 4,181,894 shares
Disclosed Ownership: 393,098 shares
Ownership: 9.4%
Form type: SCHEDULE 13G/A
Filing time: 12 Nov 2025, 10:29:36 UTC
Date of event: 30 Sep 2025
Previous filing: 08 Sep 2025
SEC: View on sec.gov

Reporting Managers (8)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Invus Public Equities, L.P.	8.4%	345,926	345,926	/s/ Raymond Debbane	Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC	8.4%	345,926	345,926	/s/ Raymond Debbane	Raymond Debbane, President
Invus Global Management, LLC	8.4%	345,926	345,926	/s/ Raymond Debbane	Raymond Debbane, President
Siren, L.L.C.	8.4%	345,926	345,926	/s/ Raymond Debbane	Raymond Debbane, President
Avicenna Life Sci Master Fund LP	1.2%	47,172	47,172	/s/ Raymond Debbane	Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC	1.2%	47,172	47,172	/s/ Raymond Debbane	Raymond Debbane, Chief Executive Officer
Ulys, L.L.C.	1.2%	47,172	47,172	/s/ Raymond Debbane	Raymond Debbane, President
Raymond Debbane	9.4%	393,098	393,098	/s/ Raymond Debbane	Raymond Debbane